Cardinal Health Inc (CAH) is Resumed by BofA/Merrill to Neutral

Cardinal Health Inc (CAH) was Resumed by BofA/Merrill to “Neutral”. BofA/Merrill advised their investors in a research report released on Jun 7, 2016.

Many Wall Street Analysts have commented on Cardinal Health Inc. Avondale Initiated Cardinal Health Inc on Apr 19, 2016 to “Mkt Outperform”, Price Target of the shares are set at $111.Cardinal Health Inc was Initiated by Credit Suisse to “Outperform” on Mar 16, 2016.

On the company’s financial health, Cardinal Health Inc reported $1.43 EPS for the quarter, beating the analyst consensus estimate by $ 0.10 according to the earnings call on Apr 28, 2016. Analyst had a consensus of $1.33. The company had revenue of $30662.00 million for the quarter, compared to analysts expectations of $30439.59 million. The company’s revenue was up 20.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.19 EPS.

Cardinal Health Inc closed down -0.1 points or -0.13% at $79.79 with 19,87,989 shares getting traded on Friday. Post opening the session at $79.72, the shares hit an intraday low of $79.21 and an intraday high of $79.99 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

Investors should note that on May 4, 2016, Cardinal Health Inc announced a cash dividend of $0.4489. The company’s management has announced Jun 29, 2016 as the ex-dividend date and fixed the record date on Jul 1, 2016. The payable date has been fixed on Jul 15, 2016.

In a different news, on May 23, 2016, Carole S Watkins (Chief HR Officer) sold 84,617 shares at $77.33 per share price. According to the SEC, on Nov 12, 2015, George S Barrett (Chairman and CEO) sold 54,658 shares at $87.73 per share price. On Nov 9, 2015, Falk T Stephen (EVP, Gen. Counsel & Corp. Sec.) sold 30,085 shares at $87.66 per share price, according to the Form-4 filing with the securities and exchange commission.

Cardinal Health Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States the Company’s Pharmaceutical segment distributes branded and generic pharmaceutical over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers hospitals and other healthcare providers. In China the Pharmaceutical segment distributes branded generic and specialty pharmaceutical over-the-counter healthcare and consumer products provides logistics marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical surgical and laboratory products and provides services to hospitals ambulatory surgery centers clinical laboratories and other healthcare providers.

Cardinal Health Inc

Leave a Reply

Cardinal Health Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Cardinal Health Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.